Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity - PubMed (original) (raw)
. 2004 May 15;103(10):3677-83.
doi: 10.1182/blood-2003-09-3198. Epub 2004 Jan 15.
Affiliations
- PMID: 14726373
- DOI: 10.1182/blood-2003-09-3198
Free article
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity
Sanjay Rajagopalan et al. Blood. 2004.
Free article
Abstract
Women with systemic lupus erythematosus (SLE) are at risk for premature atherothrombosis independent of Framingham risk factors. We investigated whether endothelial cell (EC) apoptosis predicts abnormal vasomotor tone and contributes to circulating tissue factor (TF) levels in this disease. Brachial artery flow-mediated dilation (FMD) and nitroglycerin-mediated dilation were determined in women with SLE, healthy control subjects, and subjects with coronary artery disease (CAD) (n = 43/group). Quantification of circulating apoptotic ECs was performed by flow cytometry (CD146(+) cells that stained for Annexin V [CD146(AnnV+)]) and immunofluorescent microscopy. Plasma TF was measured by enzyme-linked immunosorbent assay (ELISA). Compared with healthy control and CAD subjects, patients with SLE had higher numbers of circulating CD146(AnnV+) cells (10 +/- 3, 18 +/- 5, and 89 +/- 32 cells/mL, respectively, mean +/- SEM; P <.01). Increased CD146(AnnV+) cells correlated strongly with abnormal vascular function (P =.037). After adjusting for known predictors of endothelial function, CD146(AnnV+) was the only variable that predicted FMD (beta = -4.5, P <.001). Increased CD146(AnnV+) was strongly associated with elevated levels of circulating TF (r =.46, P =.002). Circulating apoptotic ECs are elevated in young women with SLE and strongly correlate with markedly abnormal vascular function and elevated TF levels. Heightened endothelial apoptosis may represent an important mechanism for development of atherothrombosis in SLE.
Similar articles
- Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
Elshal M, Abdelaziz A, Abbas A, Mahmoud K, Fathy H, El Mongy S, El-Basyuoni S, Ahmed H, McCoy P. Elshal M, et al. Nephrol Dial Transplant. 2009 May;24(5):1495-9. doi: 10.1093/ndt/gfn650. Epub 2008 Nov 27. Nephrol Dial Transplant. 2009. PMID: 19039027 - Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction.
El Solh AA, Akinnusi ME, Baddoura FH, Mankowski CR. El Solh AA, et al. Am J Respir Crit Care Med. 2007 Jun 1;175(11):1186-91. doi: 10.1164/rccm.200611-1598OC. Epub 2007 Feb 1. Am J Respir Crit Care Med. 2007. PMID: 17272785 - Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
Kiss E, Soltesz P, Der H, Kocsis Z, Tarr T, Bhattoa H, Shoenfeld Y, Szegedi G. Kiss E, et al. J Autoimmun. 2006 Dec;27(4):211-7. doi: 10.1016/j.jaut.2006.09.008. Epub 2006 Nov 7. J Autoimmun. 2006. PMID: 17088047 Review. - Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
Mauro D, Nerviani A. Mauro D, et al. Rev Recent Clin Trials. 2018;13(3):192-198. doi: 10.2174/1574887113666180314091831. Rev Recent Clin Trials. 2018. PMID: 29542419 Review.
Cited by
- Developments in the scientific understanding of lupus.
Ardoin SP, Pisetsky DS. Ardoin SP, et al. Arthritis Res Ther. 2008;10(5):218. doi: 10.1186/ar2488. Epub 2008 Oct 10. Arthritis Res Ther. 2008. PMID: 18947369 Free PMC article. Review. - Microparticles (CD146) and Arterial Stiffness Versus Carotid Intima Media Thickness as an Early Predictors of Vascular Affection in Systemic Lupus Patients.
Nassef S, El Guindey H, Fawzy M, Nasser A, Reffai R, Shemiy D. Nassef S, et al. Arch Rheumatol. 2015 Oct 6;31(1):31-40. doi: 10.5606/ArchRheumatol.2016.5716. eCollection 2016 Mar. Arch Rheumatol. 2015. PMID: 29900986 Free PMC article. - Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression.
Mak A, Kow NY, Schwarz H, Gong L, Tay SH, Ling LH. Mak A, et al. Sci Rep. 2017 Aug 4;7(1):7320. doi: 10.1038/s41598-017-07574-1. Sci Rep. 2017. PMID: 28779080 Free PMC article. - Cardiovascular disease in lupus: insights and updates.
Knight JS, Kaplan MJ. Knight JS, et al. Curr Opin Rheumatol. 2013 Sep;25(5):597-605. doi: 10.1097/BOR.0b013e328363eba3. Curr Opin Rheumatol. 2013. PMID: 23846339 Free PMC article. Review. - Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.
Somers EC, Zhao W, Lewis EE, Wang L, Wing JJ, Sundaram B, Kazerooni EA, McCune WJ, Kaplan MJ. Somers EC, et al. PLoS One. 2012;7(5):e37000. doi: 10.1371/journal.pone.0037000. Epub 2012 May 14. PLoS One. 2012. PMID: 22606325 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- 5 P30 CA46592/CA/NCI NIH HHS/United States
- AG014783/AG/NIA NIH HHS/United States
- AR42525/AR/NIAMS NIH HHS/United States
- AR48234/AR/NIAMS NIH HHS/United States
- ES011196/ES/NIEHS NIH HHS/United States
- M01-RR00042/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous